atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
atai Life Sciences (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on mental health disorder treatments, has announced its participation in the TD Cowen 45th Annual Health Care Conference in Boston, MA. The event will take place from March 3-5, 2025.
The company's management team will engage in a fireside chat scheduled for Monday, March 3 at 11:50 A.M. ET, along with one-on-one investor meetings. A webcast of the presentation will be available, with an archived replay accessible on the Investors section of atai's website under Events for up to 90 days.
atai Life Sciences (NASDAQ: ATAI), un'azienda biofarmaceutica in fase clinica focalizzata sui trattamenti per i disturbi della salute mentale, ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen a Boston, MA. L'evento si svolgerà dal 3 al 5 marzo 2025.
Il team di gestione dell'azienda parteciperà a un fireside chat programmato per lunedì 3 marzo alle 11:50 A.M. ET, insieme a incontri individuali con gli investitori. Una trasmissione in diretta della presentazione sarà disponibile, con una registrazione archiviata accessibile nella sezione Investitori del sito web di atai sotto Eventi per un massimo di 90 giorni.
atai Life Sciences (NASDAQ: ATAI), una empresa biofarmacéutica en etapa clínica centrada en tratamientos para trastornos de salud mental, ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen en Boston, MA. El evento se llevará a cabo del 3 al 5 de marzo de 2025.
El equipo directivo de la empresa participará en un fireside chat programado para el lunes 3 de marzo a las 11:50 A.M. ET, junto con reuniones individuales con inversores. Se dispondrá de una transmisión en vivo de la presentación, con una repetición archivada accesible en la sección de Inversores del sitio web de atai bajo Eventos durante un máximo de 90 días.
atai Life Sciences (NASDAQ: ATAI)는 정신 건강 장애 치료에 중점을 둔 임상 단계의 생명공학 회사로, 매사추세츠주 보스턴에서 열리는 TD Cowen 제45회 연례 건강 관리 회의에 참여한다고 발표했습니다. 이 행사는 2025년 3월 3일부터 5일까지 진행됩니다.
회사의 경영진은 3월 3일 월요일 오전 11시 50분(ET)에 예정된 fireside chat에 참여하고, 투자자와의 일대일 회의도 진행합니다. 발표의 웹캐스트가 제공되며, atai의 웹사이트 투자자 섹션의 이벤트 아래에서 최대 90일 동안 아카이브된 재생이 가능합니다.
atai Life Sciences (NASDAQ: ATAI), une entreprise biopharmaceutique en phase clinique axée sur les traitements des troubles de la santé mentale, a annoncé sa participation à la 45e Conférence Annuelle sur la Santé de TD Cowen à Boston, MA. L'événement se déroulera du 3 au 5 mars 2025.
La direction de l'entreprise participera à un fireside chat prévu pour le lundi 3 mars à 11h50 ET, ainsi qu'à des réunions individuelles avec des investisseurs. Un webinaire de la présentation sera disponible, avec une rediffusion archivée accessible dans la section Investisseurs du site web d'atai sous Événements pendant une durée maximale de 90 jours.
atai Life Sciences (NASDAQ: ATAI), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Behandlung von psychischen Erkrankungen konzentriert, hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen in Boston, MA, angekündigt. Die Veranstaltung findet vom 3. bis 5. März 2025 statt.
Das Management-Team des Unternehmens wird an einem Fireside Chat teilnehmen, der für Montag, den 3. März um 11:50 Uhr ET geplant ist, sowie an persönlichen Gesprächen mit Investoren. Ein Webcast der Präsentation wird verfügbar sein, mit einem archivierten Replay, das bis zu 90 Tage lang im Bereich Investoren auf der Website von atai unter Veranstaltungen zugänglich ist.
- None.
- None.
NEW YORK and BERLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the Company’s management team is scheduled to participate in the TD Cowen 45th Annual Health Care Conference in Boston, MA from March 3-5, 2025. Details of the company’s participation:
Format: Fireside chat and 1x1 investor meetings
Date and Time: Fireside chat on Monday, March 3 at 11:50 A.M. ET
Webcast link: Here
An archived replay will be available on the Investors section of the atai website under Events for up to 90 days.
About atai Life Sciences
atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. The Company was founded in response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to developing novel, evidence-based therapeutics to treat depression, anxiety and other mental health disorders. atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.
Contact Information
Investor Contact:
IR@atai.life
Media Contact:
PR@atai.life
FAQ
When is atai Life Sciences (ATAI) presenting at the TD Cowen Healthcare Conference 2025?
How long will the ATAI TD Cowen Conference webcast be available for replay?
What type of presentations will ATAI deliver at the TD Cowen Healthcare Conference 2025?
Where can investors access ATAI's TD Cowen Conference presentation?
